Schlumberger returned for the first close of the round, helping the emissions monitoring technology developer take its total funding to $55m.

Small molecule drug developer C4 has fied for a $100m initial public offering, three months after the Dana-Farber Cancer Institute spinout raised a $170m round.

Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,

The MSU cancer drug spinout has been acquired on the strength of its expertise in proteasome inhibitors and preclinical pipeline.

American Express Ventures returned to reinvest in the financial intelligence provider as part of a series B round announced in tandem with a company rebrand.

Merck Global Health Innovation Fund has contributed to a $47.5m round for AeroSafe Global, which provides cold supply chain services to pharmaceutical clients.

State Farm Ventures and existing investor Bloomberg Beta helped the call centre technology provider close a round that will support R&D and hiring.

Long-term investor OATV returned to invest in the luxury furniture marketplace for a fourth time, expanding its overall funding to more than $48m.

Black Founders Development Fund will make early-stage investments to drive Accenture Ventures' engagement with black entrepreneurs.

Exosome therapy developer Codiak Biosciences – based on research at Gothenburg and MD Anderson Cancer Center – has filed to raise up to $100m.